$TWST
Twist Bioscience Corp

2022 Q1 Form 10-Q Financial Statement

#000162828022013045 Filed on May 06, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $48.13M $42.02M $31.20M
YoY Change 54.23% 49.21% 61.7%
Cost Of Revenue $29.71M $27.06M $19.03M
YoY Change 56.16% 48.97% 40.28%
Gross Profit $18.41M $14.96M $12.18M
YoY Change 51.22% 49.63% 112.38%
Gross Profit Margin 38.26% 35.61% 39.02%
Selling, General & Admin $54.00M $51.10M $34.39M
YoY Change 57.02% 77.47% 26.48%
% of Gross Profit 293.26% 341.52% 282.43%
Research & Development $31.23M $22.63M $15.79M
YoY Change 97.78% 61.64% 48.57%
% of Gross Profit 169.61% 151.25% 129.69%
Depreciation & Amortization $3.968M $3.150M $2.470M
YoY Change 60.65% 49.22% 59.35%
% of Gross Profit 21.55% 21.05% 20.29%
Operating Expenses $85.23M $73.73M $50.18M
YoY Change 69.85% 72.29% 32.68%
Operating Profit -$60.80M -$55.94M -$38.00M
YoY Change 59.99% 70.59% 18.44%
Interest Expense $29.00K $26.00K $95.00K
YoY Change -69.47% -77.97% -55.81%
% of Operating Profit
Other Income/Expense, Net -$245.0K -$156.0K $84.00K
YoY Change -391.67% 102.6% 366.67%
Pretax Income -$60.82M -$55.97M -$37.86M
YoY Change 60.65% 70.35% 19.4%
Income Tax -$149.0K -$10.41M $61.00K
% Of Pretax Income
Net Earnings -$60.67M -$45.56M -$37.92M
YoY Change 59.99% 38.49% 19.36%
Net Earnings / Revenue -126.06% -108.44% -121.52%
Basic Earnings Per Share -$1.13 -$0.91 -$0.78
Diluted Earnings Per Share -$1.13 -$912.9K -$0.78
COMMON SHARES
Basic Shares Outstanding 53.47M shares 49.63M 48.71M shares
Diluted Shares Outstanding 53.47M shares 49.91M shares 48.71M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $573.9M $301.9M $555.7M
YoY Change 3.27% -48.6% 141.5%
Cash & Equivalents $407.6M $191.6M $399.3M
Short-Term Investments $166.2M $110.2M $156.3M
Other Short-Term Assets $11.05M $10.04M $9.200M
YoY Change 20.1% 22.4% 100.0%
Inventory $44.59M $40.24M $15.84M
Prepaid Expenses
Receivables $34.88M $32.87M $27.29M
Other Receivables $6.356M $5.834M $3.100M
Total Short-Term Assets $664.4M $385.0M $608.0M
YoY Change 9.27% -39.31% 133.66%
LONG-TERM ASSETS
Property, Plant & Equipment $91.81M $65.14M $31.98M
YoY Change 187.14% 9.47% 37.43%
Goodwill $85.68M $84.24M $1.138M
YoY Change 7428.82% 0.0%
Intangibles
YoY Change
Long-Term Investments $30.59M $106.8M
YoY Change
Other Assets $6.902M $7.425M $3.447M
YoY Change 100.23% 72.67% 42.2%
Total Long-Term Assets $357.3M $401.2M $69.29M
YoY Change 415.6% 515.28% 8.83%
TOTAL ASSETS
Total Short-Term Assets $664.4M $385.0M $608.0M
Total Long-Term Assets $357.3M $401.2M $69.29M
Total Assets $1.022B $786.2M $677.3M
YoY Change 50.84% 12.37% 109.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.82M $23.07M $8.528M
YoY Change 97.17% 159.25% 23.02%
Accrued Expenses $15.94M $11.69M $3.272M
YoY Change 387.22% -45.65% -6.27%
Deferred Revenue $600.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $3.168M
YoY Change -100.0% -100.0% -4.95%
Total Short-Term Liabilities $84.63M $80.03M $40.44M
YoY Change 109.27% 115.73% 33.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $8.147M $19.67M $422.0K
YoY Change 1830.57% -17.7% 344.21%
Total Long-Term Liabilities $8.147M $19.67M $422.0K
YoY Change 1830.57% -19.71% -86.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $84.63M $80.03M $40.44M
Total Long-Term Liabilities $8.147M $19.67M $422.0K
Total Liabilities $158.3M $160.0M $63.11M
YoY Change 150.8% 159.72% 5.76%
SHAREHOLDERS EQUITY
Retained Earnings -$716.8M -$656.1M -$529.3M
YoY Change 35.42% 30.39%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $863.4M $626.2M $614.2M
YoY Change
Total Liabilities & Shareholders Equity $1.022B $786.2M $677.3M
YoY Change 50.84% 12.37% 109.12%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income -$60.67M -$45.56M -$37.92M
YoY Change 59.99% 38.49% 19.36%
Depreciation, Depletion And Amortization $3.968M $3.150M $2.470M
YoY Change 60.65% 49.22% 59.35%
Cash From Operating Activities -$42.34M -$46.65M -$24.55M
YoY Change 72.46% 87.12% -58.16%
INVESTING ACTIVITIES
Capital Expenditures -$31.97M $12.78M -$8.400M
YoY Change 280.6% 252.25% 206.57%
Acquisitions $8.160M
YoY Change
Other Investing Activities $18.68M -$213.8M $81.99M
YoY Change -77.22% 405.55% 160.29%
Cash From Investing Activities -$13.29M -$226.6M $73.59M
YoY Change -118.06% 393.42% 155.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 271.6M -1.011M 1.450M
YoY Change 18632.14% -100.31% -99.23%
NET CHANGE
Cash From Operating Activities -42.34M -46.65M -24.55M
Cash From Investing Activities -13.29M -226.6M 73.59M
Cash From Financing Activities 271.6M -1.011M 1.450M
Net Change In Cash 216.0M -274.2M 50.49M
YoY Change 327.77% -207.06% -68.07%
FREE CASH FLOW
Cash From Operating Activities -$42.34M -$46.65M -$24.55M
Capital Expenditures -$31.97M $12.78M -$8.400M
Free Cash Flow -$10.37M -$59.44M -$16.15M
YoY Change -35.79% 108.1% -71.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001581280
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38720
dei Entity Registrant Name
EntityRegistrantName
Twist Bioscience Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2058888
dei Entity Address Address Line1
EntityAddressAddressLine1
681 Gateway Blvd
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
719-0671
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
TWST
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56264039 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
407627000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
465829000 USD
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
166231000 USD
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
12034000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34877000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28549000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
44591000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
31800000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11049000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8283000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
664375000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
546495000 USD
CY2022Q1 us-gaap Long Term Investments
LongTermInvestments
30587000 USD
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
0 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91814000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44122000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
546000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
78215000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61580000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
85678000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
22434000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
62493000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18262000 USD
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1572000 USD
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1530000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6902000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7674000 USD
CY2022Q1 us-gaap Assets
Assets
1021636000 USD
CY2021Q3 us-gaap Assets
Assets
702097000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
16815000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
14900000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15942000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6437000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21686000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22327000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14166000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8213000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1552000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16023000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9623000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
84632000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
63052000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
65496000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53156000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8147000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5068000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
158275000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
121276000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56234000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56234000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49499000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49499000 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1580620000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1190828000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-475000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-716784000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-610553000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
863361000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
580821000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1021636000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
702097000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
48127000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31204000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90145000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59364000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
29714000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
19028000 USD
us-gaap Cost Of Revenue
CostOfRevenue
56770000 USD
us-gaap Cost Of Revenue
CostOfRevenue
37190000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31231000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15791000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53861000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29791000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53998000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34389000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
105096000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63181000 USD
CY2022Q1 twst Change In Fair Value Of Contingent Consideration And Indemnity Holdback
ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback
6014000 USD
CY2021Q1 twst Change In Fair Value Of Contingent Consideration And Indemnity Holdback
ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback
0 USD
twst Change In Fair Value Of Contingent Consideration And Indemnity Holdback
ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback
8840000 USD
twst Change In Fair Value Of Contingent Consideration And Indemnity Holdback
ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback
0 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
108929000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
69208000 USD
us-gaap Costs And Expenses
CostsAndExpenses
206887000 USD
us-gaap Costs And Expenses
CostsAndExpenses
130162000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-60802000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-38004000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-70712000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-149000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-116742000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-70798000 USD
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
259000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
157000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
412000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
291000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
29000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
95000 USD
us-gaap Interest Expense
InterestExpense
54000 USD
us-gaap Interest Expense
InterestExpense
213000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-245000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
84000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-401000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-60817000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37858000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-116785000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37871000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10554000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
107000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-60668000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-37919000 USD
us-gaap Net Income Loss
NetIncomeLoss
-106231000 USD
us-gaap Net Income Loss
NetIncomeLoss
-70819000 USD
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1113000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
10000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1389000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
275000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
38000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
368000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
102000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-61506000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-107252000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-70716000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.13
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.13
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.50
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53472000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53472000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48709000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48709000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51673000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51673000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47340000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47340000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
626178000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
17682000 USD
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
269818000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
896000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2395000 USD
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1493000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4608000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22465000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-838000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-60668000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
863361000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
637952000 USD
CY2021Q1 twst Prior Quarter Public Offering Expenses Adjustment
PriorQuarterPublicOfferingExpensesAdjustment
36000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3066000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2787000 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3341000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11552000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
48000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-37919000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
614181000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
580821000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
17682000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
269818000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3934000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2395000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4050000 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
77122000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40573000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1021000 USD
us-gaap Profit Loss
ProfitLoss
-106231000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
863361000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
336262000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
21113000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
323887000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9137000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2787000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5751000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18575000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
103000 USD
us-gaap Profit Loss
ProfitLoss
-70819000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
614181000 USD
us-gaap Profit Loss
ProfitLoss
-106231000 USD
us-gaap Profit Loss
ProfitLoss
-70819000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7118000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4575000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
11045000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000 USD
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
1609000 USD
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
214000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
40573000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
18575000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-790000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-314000 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
3000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
44000 USD
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-180000 USD
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
417000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-4000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-53000 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
8840000 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2731000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-3873000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1400000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis
166200000 USD
twst Property Plant And Equipment Writeoff
PropertyPlantAndEquipmentWriteoff
70000 USD
twst Property Plant And Equipment Writeoff
PropertyPlantAndEquipmentWriteoff
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3845000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1331000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12787000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3544000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1407000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
87000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-762000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3798000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1885000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-45000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-653000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-38000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
832000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1126000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-88993000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49481000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
44753000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12030000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8160000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
217639000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
58795000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
30676000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
98494000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-239876000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27669000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4000000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
9116000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
269818000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
323887000 USD
us-gaap Interest Paid Net
InterestPaidNet
109000 USD
twst Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
2395000 USD
twst Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
2787000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1558000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1667000 USD
twst Payments To Repurchases Of Common Stock For Tax Withholding
PaymentsToRepurchasesOfCommonStockForTaxWithholding
4050000 USD
twst Payments To Repurchases Of Common Stock For Tax Withholding
PaymentsToRepurchasesOfCommonStockForTaxWithholding
5751000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
270605000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
328372000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-58160000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
306613000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
467359000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94246000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
409199000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
400859000 USD
us-gaap Interest Paid Net
InterestPaidNet
9000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
130000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
8737000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
197000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
19494000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
63000 USD
us-gaap Stock Issued1
StockIssued1
77122000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-716800000 USD
CY2022Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
17098000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
442472000 USD
CY2021Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
9856000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
30600000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
407627000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
465829000 USD
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1572000 USD
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1530000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
409199000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
467359000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
546095000 USD
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
8500000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-2800000 USD
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5700000 USD
CY2022Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
28674000 USD
CY2021Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
26549000 USD
CY2022Q1 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
6356000 USD
CY2021Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
2337000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
153000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
337000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34877000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28549000 USD
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
31975000 USD
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
18778000 USD
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
3048000 USD
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
4837000 USD
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9568000 USD
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8185000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
44591000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
31800000 USD
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1200000 USD
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1900000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15942000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6437000 USD
CY2022Q1 twst Convertible Note Receivable
ConvertibleNoteReceivable
3081000 USD
CY2021Q3 twst Convertible Note Receivable
ConvertibleNoteReceivable
3021000 USD
CY2022Q1 twst Other Assets Noncurrent Excluding Convertible Receivable
OtherAssetsNoncurrentExcludingConvertibleReceivable
3821000 USD
CY2021Q3 twst Other Assets Noncurrent Excluding Convertible Receivable
OtherAssetsNoncurrentExcludingConvertibleReceivable
4653000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6902000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7674000 USD
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6163000 USD
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5057000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9779000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1380000 USD
CY2022Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
5880000 USD
CY2021Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
4643000 USD
CY2022Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
5838000 USD
CY2021Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
8584000 USD
CY2022Q1 twst Accrued Commissions Current
AccruedCommissionsCurrent
3853000 USD
CY2021Q3 twst Accrued Commissions Current
AccruedCommissionsCurrent
3330000 USD
CY2022Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
4952000 USD
CY2021Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
4676000 USD
CY2022Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1163000 USD
CY2021Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1094000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21686000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22327000 USD
CY2021Q3 twst Other Liabilities Non Current Other Than Contingent Consideration
OtherLiabilitiesNonCurrentOtherThanContingentConsideration
397000 USD
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
10004000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5186000 USD
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
3588000 USD
CY2021Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
2440000 USD
CY2022Q1 twst Other Liabilities Current Other Than Contingent Consideration And Taxes
OtherLiabilitiesCurrentOtherThanContingentConsiderationAndTaxes
2431000 USD
CY2021Q3 twst Other Liabilities Current Other Than Contingent Consideration And Taxes
OtherLiabilitiesCurrentOtherThanContingentConsiderationAndTaxes
1997000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16023000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9623000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18262000 USD
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
7093000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
4671000 USD
CY2022Q1 twst Other Liabilities Non Current Other Than Contingent Consideration
OtherLiabilitiesNonCurrentOtherThanContingentConsideration
1054000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8147000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5068000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2300000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
66130000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3637000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
62493000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19630000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1368000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
78215000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
6000000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14166000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14166000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
65496000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
65496000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7100000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7140000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
13987000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
13372000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
13706000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12280000 USD
CY2022Q1 twst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
96817000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
157302000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
60012000 USD
CY2022Q1 twst Tenant Improvement Allowance
TenantImprovementAllowance
17628000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
79662000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14166000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
65496000 USD
CY2022Q1 us-gaap Tenant Improvements
TenantImprovements
17600000 USD
twst Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
16600000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
18200000 USD
twst Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
2700000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
2500000 USD
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
3900000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
7400000 USD
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3200000 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P15Y6M
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0645
CY2015Q4 twst Class Of Warrants Or Rights Number Of Warrants Issued During The Period
ClassOfWarrantsOrRightsNumberOfWarrantsIssuedDuringThePeriod
18854 shares
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2022Q1 twst Business Acquisition Income Tax Benefit Due To Deferred Tax Liability
BusinessAcquisitionIncomeTaxBenefitDueToDeferredTaxLiability
100000 USD
twst Business Acquisition Income Tax Benefit Due To Deferred Tax Liability
BusinessAcquisitionIncomeTaxBenefitDueToDeferredTaxLiability
10600000 USD
twst Business Acquisition Income Tax Benefit Due To Deferred Tax Liability
BusinessAcquisitionIncomeTaxBenefitDueToDeferredTaxLiability
0 USD
CY2021Q1 twst Business Acquisition Income Tax Benefit Due To Deferred Tax Liability
BusinessAcquisitionIncomeTaxBenefitDueToDeferredTaxLiability
0 USD
CY2016Q1 twst Class Of Warrants Or Rights Number Of Warrants Issued During The Period
ClassOfWarrantsOrRightsNumberOfWarrantsIssuedDuringThePeriod
7531 shares
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
26385 shares
CY2020Q4 twst Stock Warrants Exercised
StockWarrantsExercised
18854 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
14.85
CY2020Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
16051 shares
CY2020Q4 twst Stock Warrants Exercised
StockWarrantsExercised
7531 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
21.24
CY2020Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
6041 shares
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11552000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22337000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40405000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18575000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
22300000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
73.39
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.50
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59364000 USD
CY2021Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
355000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
249000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
50000 shares
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
554000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.13
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-60668000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-37919000 USD
us-gaap Net Income Loss
NetIncomeLoss
-106231000 USD
us-gaap Net Income Loss
NetIncomeLoss
-70819000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53472000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53472000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48709000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48709000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51673000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51673000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47340000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47340000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.13
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90145000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59364000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.50
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5515000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5515000 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4271000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4271000 shares
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
48127000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31204000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
48127000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31204000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90145000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59364000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
48127000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31204000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90145000 USD

Files In Submission

Name View Source Status
0001628280-22-013045-index-headers.html Edgar Link pending
0001628280-22-013045-index.html Edgar Link pending
0001628280-22-013045.txt Edgar Link pending
0001628280-22-013045-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twst-20220331.htm Edgar Link pending
twst-20220331.xsd Edgar Link pending
twst-20220331x10qxex311.htm Edgar Link pending
twst-20220331x10qxex312.htm Edgar Link pending
twst-20220331x10qxex321.htm Edgar Link pending
twst-20220331x10qxex322.htm Edgar Link pending
twst-20220331_cal.xml Edgar Link unprocessable
twst-20220331_def.xml Edgar Link unprocessable
twst-20220331_g1.jpg Edgar Link pending
twst-20220331_htm.xml Edgar Link completed
twst-20220331_lab.xml Edgar Link unprocessable
twst-20220331_pre.xml Edgar Link unprocessable